| 1. |
Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy[J]. Retina, 1995, 15(2): 100-110. DOI: 10.1097/00006982-199515020-00003. DOI: 10.1097/00006982-199515020-00003.
|
| 2. |
Han LH, Yuan LF, Liang X, et al. Combined therapy versus anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy: a meta-analysis[J]. Int Ophthalmol, 2017, 10(8): 1280-1289. DOI: 10.18240/ijo.2017.08.16.
|
| 3. |
Lin HC, Yang CH, Yang CM, et al. Visual outcomes of vitrectomy for polypoidal choroidalvasculopathy-related breakthrough vitreoushaemorrhage[J]. Eye, 2014, 28(7): 797-806. DOI: 10.1038/eye.2014.124.
|
| 4. |
李莉, 梁永波, 陈玲, 等. 核固红染液不同配制方法对含铁血黄素染色的影响[J]. 临床与实验病理学杂志, 2020, 36(7): 861-863. DOI: 10.13315/j.cnki.cjcep.2020.07.030.Li L, Liang YB, Chen L, et al. Effect of different preparation methods of nuclear solid red dye on hemosiderin staining[J]. J Clin Exp Pathol, 2020, 36(7): 861-863. DOI: 10.13315/j.cnki.cjcep.2020.07.030.
|
| 5. |
Lincoff H, Madjarov B, Lincoff N, et al. Pathogenesis of thevitreous cloud emanating from subretinal hemorrhage[J]. Arch Ophthalmol, 2003, 121(1): 91-96. DOI: 10.1001/archopht.121.1.91.
|
| 6. |
Jalali S, Parra SL, Majji AB, et al. Ultrasonographic characteristics and treatment outcomes of surgery for vitreous hemorrhage in idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2006, 142(4): 608-619. DOI: 10.1016/j.ajo.2006.05.055.
|
| 7. |
张霜, 张杰, 徐鑫彦, 等. 组织型纤溶酶原激活剂、雷珠单抗联合C3F8治疗息肉样脉络膜血管病变并发早期黄斑下出血的疗效观察[J]. 中华眼底病杂志, 2018, 34(5): 448-452. DOI: 10.3760/cma.j.issn.1005-1015.2018.05.007.Zhang S, Zhang J, Xu XY, et al. The efficacy of intravitreal injection of tissue plasminogen activator, ranibizumab and C3F8 in the treatment of early submacular hemorrhage induce to polypoid choroid vasculopathy[J]. Chin J Ocul Fundus Dis, 2018, 34(5): 448-452. DOI: 10.3760/cma.j.issn.1005-1015.2018.05.007.
|
| 8. |
Zhao XY, Luo MY, Meng LH, et al. The incidence, characteristics, . management, progrosis and classifceation of breakthrough vite ous hemorhage secondary to polypoidal choroidal vasculopathy[J]. Retina, 2021, 41(8): 1675-1685. DOI: 10.1097/IAE.0000000000003098.
|
| 9. |
周海英, 纪海霞, 杨萱, 等. 玻璃体切除术治疗息肉样脉络膜血管病变继发玻璃体积血的疗效及影响因素[J]. 眼科, 2022, 31(3): 181-187. DOI: 10.13281/j.cnki.issn.1004-4469.2022.03.004.Zhou HY, Ji HX, Yang X, et al. Efficacy and effective factors of vitrectomy for vitreous hemorrhage secondary to polypoidal choroidal vasculopathy[J]. Ophthalmol CHN, 2022, 31(3): 181-187. DOI: 10.13281/j.cnki.issn.1004-4469.2022.03.004.
|
| 10. |
毛子清, 吴宏禧, 邹玉凌, 等. 息肉样脉络膜血管病变眼内出血的内外路联合手术疗效观察[J]. 中华眼底病杂志, 2020, 36(7): 504-508. DOI: 10.3760/cma.j.cn511434-20190412-00145.Mao ZQ, Wu HX, Zou YL, et al. Curative effect of internal and external combined surgery for intraocular hemorrhage of polypoidal choroidal vascular disease[J]. Chin J Ocul Fundus Dis, 2020, 36(7): 504-508. DOI: 10.3760/cma.j.cn511434-20190412-00145.
|
| 11. |
徐恩沛, 孙先勇, 高荣玉, 等. 视网膜下抽液联合玻璃体内注射康柏西普和气体治疗息肉样脉络膜血管病变并发浆液性视网膜色素上皮脱离的疗效和安全性[J]. 眼科新进展, 2024, 44(3): 208-212. DOI: 10.13389/j.cnki.rao.2024.0041.Xu EP, Sun XY, Gao RY, et al. Efficacy and safety of subretinal fluid extraction combined with intravitreal injection of conbercept and gas in the treatment of polypoidal choroidal vasculopathy complicated with serous retinal pigment epithelium detachment[J]. Rec Adv Ophthalmol, 2024, 44(3): 208-212. DOI: 10.13389/j.cnki.rao.2024.0041.
|
| 12. |
杨秀芬, 赵露, 尤冉, 等. 视网膜切开治疗息肉样脉络膜血管病变伴出血性视网膜脱离2例[J]. 临床眼科杂志, 2018, 26(2): 182-183. DOI: 10.3969/j.issn.1006-8422.2018.02.026.Yang XF, Zhao L, You R, et al. Two cases of polypoid choroidal vasculopathy with hemorrhagic retinal detachment treated by retinotomy[J]. J Clin Ophthalmol, 2018, 26(2): 182-183. DOI: 10.3969/j.issn.1006-8422.2018.02.026.
|
